Corline Biomedical AB (FRA:IZ7) Change In Inventory: €-0.12 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:IZ7 Corline Biomedical AB FRA:IZ7
43 GF Score
Price €1.45
GF Value €0.79
! 4 Warning Signs
View Full Analysis

What is Corline Biomedical AB Change In Inventory?

Corline Biomedical AB FRA:IZ7 -0.69% 43 Change In Inventory is €-0.12 Mil as of Jun. 2026. GuruFocus rates FRA:IZ7 with a GF Score™ of 43/100 and a GF Value™ of €0.79. The stock has 4 warning signs investors should review.

Corline Biomedical AB's change in inventory for the quarter that ended in Jun. 2026 was €-0.05 Mil. It means Corline Biomedical AB's inventory increased by €0.05 Mil from Mar. 2026 to Jun. 2026 .

Corline Biomedical AB's change in inventory for the fiscal year that ended in Dec. 2025 was €0.00 Mil. It means Corline Biomedical AB's inventory stayed the same from Dec. 2024 to Dec. 2025 .

Corline Biomedical AB's Total Inventories for the quarter that ended in Jun. 2026 was €0.12 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Corline Biomedical AB's Days Inventory for the quarter that ended in Jun. 2026 was 821.25.

Inventory Turnover measures how fast the company turns over its inventory within a year. Corline Biomedical AB's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Corline Biomedical AB's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.23.

Corline Biomedical AB  (FRA:IZ7) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Corline Biomedical AB's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0.099/0.011*365 / 4
=821.25

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Corline Biomedical AB's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.011 / 0.099
=0.11

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Corline Biomedical AB's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0.099 / 0.428
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corline Biomedical AB Change In Inventory Related Terms

Corline Biomedical AB Change In Inventory Historical Data

* Premium members only.

The historical data trend for Corline Biomedical AB's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corline Biomedical AB Change In Inventory Chart

Corline Biomedical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Corline Biomedical AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.08 -0.05
FRA:IZ7
43GF Score
Corline Biomedical AB FRA:IZ7
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Corline Biomedical AB Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €-0.12 Mil mean?
Corline Biomedical AB (FRA:IZ7) has a Change In Inventory of €-0.12 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Corline Biomedical AB and its competitors.
Is Corline Biomedical AB's Change In Inventory too high?
Corline Biomedical AB's current Change In Inventory is €-0.12 Mil. Overall, Corline Biomedical AB has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Corline Biomedical AB's Change In Inventory compare to VRTX and REGN?
Corline Biomedical AB's Change In Inventory of €-0.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Corline Biomedical AB and its competitors. Corline Biomedical AB's current Change In Inventory is €-0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corline Biomedical AB stock overvalued right now?
Corline Biomedical AB (FRA:IZ7) has a current Change In Inventory of €-0.12 Mil. The stock's GF Value™ is €0.79, compared to a current price of €1.45 — trading 82.9% above its estimated fair value. The current Change In Inventory is €-0.12 Mil. Corline Biomedical AB's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Corline Biomedical AB (FRA:IZ7), the current Change In Inventory is €-0.12 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Corline Biomedical AB (FRA:IZ7) Overvalued in 2026?

Based on GuruFocus' analysis, Corline Biomedical AB stock appears to be overvalued. The current stock price of €1.45 is trading 82.9% above its estimated GF Value™ of €0.79.

Key valuation signals for FRA:IZ7:

  • Change In Inventory: €-0.12 Mil
  • GF Value™: €0.79 vs. price of €1.45 (82.9% above fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the FRA:IZ7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Corline Biomedical AB Business Description

Other Exchanges CLBIO:Sweden
Address Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB offers customers in the medical technology industry and regenerative medicine as well as transplant clinics products to manage immune thrombosis. The company offers a proprietary surface treatment technology, Corline Heparin Surface (CHS), which can be used in combination with all commonly used implant materials such as polymers (plastics) and various metals, but also for equipment where blood circulation occurs outside the body.
43GF Score

Get the complete analysis for FRA:IZ7

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.45
Price
€0.79
GF Value